digital currency trend Top Knowledge

Microsoft is reported to have hired several DeepMind employees for the new AI health department. Mustafa Suleyman, the head of Microsoft consumer artificial intelligence and co-founder of DeepMind, is forming a new team focusing on consumer health. Dominic King, the former head of DeepMind health department, was hired as the vice president of Microsoft AI's new health team in London. He also poached DeepMind's clinical research scientist and Christopher Kelly, a neonatal intensive care doctor at Evelina Children's Hospital in London, and two other colleagues he worked with during DeepMind.The chairman of Japan's trade union called on the government to speed up its efforts to raise wages, and the chairman of Japan's Metal Workers' Union urged the government to speed up the pace of wage increase, while expressing concern about the premature tightening measures taken by the Bank of Japan. Akihiro Kaneko, president of the Board of Directors of the Japan Metal Workers' Union, said that we need to see the situation improve this year when talking about the government's measures to help small and medium-sized enterprises pass on costs to consumers through the supply chain. If we put off this effort for five or ten years, there will never be any improvement. Kaneko's remarks come as Japan prepares for annual wage negotiations, which will culminate this spring. In next year's negotiations, the union announced a record target of a monthly salary increase of 12,000 yen (US$ 79) or more. Kaneko said that we need to send a clear message that our salary increase target (this year) is higher.The seminar on the listing, cultivation and market of 2024 magnesium futures was held. According to the news of China Nonferrous Metals Industry Association Magnesium Branch, on December 10th, the seminar on the listing, cultivation and market of 2024 magnesium futures was successfully held in Yuncheng City, Shanxi Province. During the meeting, the leaders of major domestic magnesium smelting enterprises held a symposium, made an in-depth analysis of the current supply and demand of raw magnesium market, and put forward countermeasures. The meeting unanimously agreed to take three measures: first, magnesium smelting enterprises jointly reduce production to make the supply and demand reasonably match; Second, Yulin Magnesium Group continued to collect and store, alleviating the financial pressure on producers; The third is to explore the guiding price mechanism linked to aluminum, and establish a quotation and trading platform for raw magnesium as soon as possible to standardize market behavior. The above measures aim to restore the magnesium price to a reasonable price as soon as possible and keep it relatively stable for a long time, so that all links in the upstream and downstream of the industrial chain can obtain reasonable profits, dispel market doubts, stabilize market expectations, expand the industrial scale and boost the high-quality development of the industry.

Sanofi flu and COVID-19 vaccine get FDA fast track.IDF: Two rockets fired from Gaza not long ago landed in an open area, causing no damage.The Nikkei 225 index just broke through the 39,300.00 mark, and the latest report was 39,302.42, down 0.17% in the day.

Australia's S&P/ASX 200 index closed down 0.5% to 8,353.60 points.The main contract of the container transport index (European line) fell more than 4.00% in the day and is now reported at 2436.2 points.The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.